VCYT Competitors & Alternatives
Compare Veracyte Inc with similar stocks in the same industry
Diagnostics & Research
VCYT
Main Stock$46.32
Tradestie Score
51
Market Cap
$2.85B
P/E Ratio
51.6
Revenue Growth
0.2%
Analyst Upside
+22.1%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$138.60
|
$6.42B | 244.9 | 54 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$63.78
|
$6.00B | - | 49 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.86
|
$4.60B | 42.5 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$65.11
|
$3.26B | - | 63 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$68.56
|
$2.24B | - | 51 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$22.57
|
$2.22B | - | 59 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$91.55
|
$1.77B | - | 54 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$47.27
|
$1.54B | - | 52 | Compare |
|
NEOG
Neogen Corp
|
$12.04
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.32
|
$1.23B | - | 50 | Compare |
More VCYT Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry